Ayanna and our movement just secured an important victory for reproductive justice in our country:
The U.S. Food and Drug Administration heeded our calls and eliminated the in-person requirement to obtain mifepristone, a prescription medication that’s used to safely end early pregnancies in the United States.
Mifepristone has helped millions of people maintain control over their reproductive health and future — but the FDA’s longstanding requirement to pick up this essential medication in-person was burdensome, medically unnecessary, and stigmatized safe, simple abortion care.
The FDA’s decision to lift this requirement will help ensure more people — including low-income people, Black, brown, LBTQ+ folx, and others who face unique barriers to accessing in-person care — are able to get the abortion care they need.
Abortion care is health care, and Ayanna is fighting to ensure it’s accessible to everyone who needs it, without unjust and unnecessary barriers.
Ayanna is at the forefront of the fight for reproductive justice in Congress, and we’re making important progress to expand access and affirm abortion care as a fundamental human right.
As we face continued attacks on our reproductive freedom and bodily autonomy, this work has never been more urgent.
In solidarity,
The A-Team
 |
 |
 |
Paid for by the Committee to Elect Ayanna Pressley
This email was sent to [email protected]. Email is the most important way we keep in touch with our supporters. But, if you'd like to receive fewer emails, you can do so here. If you need to remove yourself from our email list, click here to unsubscribe. If you need to update your information, click here to do so. To contribute via check, please address to Committee to Elect Ayanna Pressley, PO Box 240912, 554 Washington Street, Dorchester Center, MA 02124.
Email us: [email protected]